Products in Development
All products on this page are in development, and not approved/cleared for commercial use by any Regulatory agency.
01
Product
sEEG-based
Drug Delivery System
Diagnostic and therapeutic capabilities in one device
PRODUCT IN DEVELOPMENT
An innovative platform integrating CED (Convection Enhanced Delivery) with sEEG (Stereoelectroencephalography)
Designed as follows:
Enables real-time monitoring of neural activity before and after drug infusion
Minimally invasive, low-profile system with procedural flexibility
Potential for clinical cost efficiency by eliminating OR and MRI
Software agnostic application
*CAUTION: Device and tools for use in investigational studies in humans and for research in laboratory animals. Device and tools are under development and not approved/cleared by FDA or any Regulatory Agency for sale.
System features Under Design:
Ultra-thin diameter device for reduced brain tissue
disruption
Accommodates multiple trajectories
Not conditional
to skull maturity
Ability to perform infusion bedside
Repeated doses possible with single implant using multiple catheters
Enhanced coverage and potential for reduce toxicity
Multiple injections
for better coverage
Multimodal system
(ability to record, stimulate and deliver drugs)
Technology available in 3 sizes* for R&D and animal study use, with the potential for future investigational clinical studies
Neural recordings anticipated to aid in the assessments of drug efficacy, dosing, toxicity, mechanisms of action and biomarkers across species
Potential to reduce drug failure rates and improve clinical outcomes
Potential to streamline drug discovery process
*CAUTION: Device and tools for use in investigational studies in humans and for research in laboratory animals. Device and tools are under development and not approved/cleared by FDA or any Regulatory Agency for sale.
Mini version
Devised for small animal models (rodents). Early stages of drug development and screening
Compact version
Devised for medium/large animal models. From discovery phase to preparation for clinical trials
Standard version
Devised for humans. Investigational Clinical studies
02
Product
Percutaneously implanted
paddle lead for Spinal Cord
Stimulation (SCS)
Next Gen Perc‑Paddle Lead
Designed as follows:
Combines paddle lead advantages with ease of use of traditional perc leads
Over 20 times thinner than traditional paddle leads
True percutaneous placement with a standard 14‑gauge needle
The following are design features under development:
Percutaneous
Implantation
Great
Steerability
Easy
Deployment
Mediolateral Coverage and Focused Stimulation
Ultra-thin profile
Typical Paddle Lead
03
Product
